{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:49:42Z","timestamp":1779936582217,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T00:00:00Z","timestamp":1557619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.pmedr.2019.100892","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T15:58:16Z","timestamp":1558108696000},"page":"100892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["High-risk opioid prescribing trends in the outpatient setting prior to issuance of federal guidance"],"prefix":"10.1016","volume":"15","author":[{"given":"Alyssa M.","family":"Peckham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Fairman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Awanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-636X","authenticated-orcid":false,"given":"Nicole K.","family":"Early","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmedr.2019.100892_bb0005","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.pmedr.2019.100892_bb0010","series-title":"MMWR Recomm Rep. 65(No. RR-1)","first-page":"1","article-title":"CDC guideline for prescribing opioids for chronic pain \u2014 United States","author":"Dowell","year":"2016"},{"key":"10.1016\/j.pmedr.2019.100892_bb0015","article-title":"Diagnosis and treatment of ADHD in the United States","author":"Fairman","year":"2017","journal-title":"J. Atten. Disord."},{"issue":"9","key":"10.1016\/j.pmedr.2019.100892_bb0020","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.14930","article-title":"Opioids and other central nervous system-active polypharmacy in older adults in the United States","volume":"65","author":"Gerlach","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"issue":"26","key":"10.1016\/j.pmedr.2019.100892_bb0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.pmedr.2019.100892_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ypmed.2019.02.018","article-title":"Prescription opioid misuse among middle-aged and older adults in the United States, 2015\u20132016","volume":"121","author":"Han","year":"2019","journal-title":"Prev. Med."},{"key":"10.1016\/j.pmedr.2019.100892_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmedr.2017.12.010","article-title":"Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993\u20132014","volume":"9","author":"Hirschtritt","year":"2018","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.pmedr.2019.100892_bb0040","author":"Hsiao"},{"issue":"1","key":"10.1016\/j.pmedr.2019.100892_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2105\/AJPH.2017.304142","article-title":"Increasing prescription opioid and heroin overdose mortality in the United States, 1999\u20132014: an age-period-cohort analysis","volume":"108","author":"Huang","year":"2018","journal-title":"Am. J. Public Health"},{"issue":"335","key":"10.1016\/j.pmedr.2019.100892_bb0050","article-title":"Age-related diseases and clinical and public health implications for the 85 years old and over population","volume":"5","author":"Jaul","year":"2017","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.pmedr.2019.100892_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am. J. Prev. Med."},{"issue":"j1224","key":"10.1016\/j.pmedr.2019.100892_bb0060","article-title":"The growing problem of co-treatment with opioids and benzodiazepines","volume":"356","author":"Kacara-Mandic","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pmedr.2019.100892_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/15360288.2015.1037521","article-title":"The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the Federal response","volume":"29","author":"Kanouse","year":"2015","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"6","key":"10.1016\/j.pmedr.2019.100892_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2018.0544","article-title":"Physician prescribing of opioids to patients at increased risk of overdose from benzodiazepine use in the United States","volume":"75","author":"Ladapo","year":"2018","journal-title":"JAMA Psychiat."},{"issue":"11","key":"10.1016\/j.pmedr.2019.100892_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jagp.2016.06.003","article-title":"A systematic review of opioid and benzodiazepine misuse in older adults","volume":"24","author":"Maree","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pmedr.2019.100892_bb0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.addbeh.2018.11.010","article-title":"Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States","volume":"90","author":"McCabe","year":"2019","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.pmedr.2019.100892_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gerinurse.2018.06.001","article-title":"Prevalence and characteristics associated with high dose opioid users among older adults","volume":"40","author":"Musich","year":"2019","journal-title":"Geriatr. Nurs."},{"key":"10.1016\/j.pmedr.2019.100892_bb0090","unstructured":"Myrick, KL, n.d. Understanding and Analyzing Ambulatory Health Care Data \u2013 The NAMCS & NHAMCS: Basic Data Analysis. National Center for Health Statistics. https:\/\/www.cdc.gov\/nchs\/ppt\/nchs2015\/Myrick_Monday_GlenEcho_A2.pdf"},{"key":"10.1016\/j.pmedr.2019.100892_bb0095","author":"National Center for Health Statistics"},{"key":"10.1016\/j.pmedr.2019.100892_bb0100","author":"National Center for Health Statistics"},{"key":"10.1016\/j.pmedr.2019.100892_bb0105","author":"National Institute on Drug Abuse"},{"issue":"1","key":"10.1016\/j.pmedr.2019.100892_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4088\/JCP.12m07975","article-title":"Trends in office-based treatment of adults with stimulants in the United States","volume":"74","author":"Olfson","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pmedr.2019.100892_bb0115","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.pmedr.2019.100892_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1526-4637.2011.01260.x","article-title":"A history of being prescribed controlled substances and risk of drug overdose death","volume":"13","author":"Paulozzi","year":"2012","journal-title":"Pain Med."},{"issue":"9","key":"10.1016\/j.pmedr.2019.100892_bb0125","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","article-title":"Opioid overdose mortality among former North Carolina inmates: 2000\u20132015","volume":"108","author":"Ranapurwala","year":"2018","journal-title":"Am. J. Public Health"},{"issue":"6","key":"10.1016\/j.pmedr.2019.100892_bb0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40258-018-0402-x","article-title":"The economic burden of abuse of prescription opioids: a systematic literature review from 2012 to 2017","volume":"16","author":"Reinhart","year":"2018","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"4","key":"10.1016\/j.pmedr.2019.100892_bb0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11606-009-1218-z","article-title":"Relationship of opioid use and dosage levels to fractures in older chronic pain patients","volume":"25","author":"Saunders","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.pmedr.2019.100892_bb0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/gps.4999","article-title":"Prescription opioid and benzodiazepine misuse is associated with suicidal ideation in older adults","volume":"34","author":"Schepis","year":"2019","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"22","key":"10.1016\/j.pmedr.2019.100892_bb0145","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1001\/archinternmed.2010.450","article-title":"The comparative safety of opioids for nonmalignant pain in older adults","volume":"170","author":"Solomon","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.pmedr.2019.100892_bb0150","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.pmedr.2019.100892_bb0155","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.pmedr.2019.100892_bb0160","author":"U.S. Food and Drug Administration"},{"issue":"5","key":"10.1016\/j.pmedr.2019.100892_bb0165","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.pmedr.2019.100892_bb0170","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.drugalcdep.2018.08.013","article-title":"Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: results from electronic health records data","volume":"192","author":"Wu","year":"2018","journal-title":"Drug Alcohol Depend."}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335519300713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335519300713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T17:51:48Z","timestamp":1737654708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335519300713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"alternative-id":["S2211335519300713"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2019.100892","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-risk opioid prescribing trends in the outpatient setting prior to issuance of federal guidance","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2019.100892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100892"}}